Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data

BMC Research Notes

Volumn 10, Issue 1, 2017, Pages

  Marrie, Ruth Ann ^a,d   Walld, Randy ^a   Bolton, James M ^a   Sareen, Jitender ^a   Walker, John R ^a   Patten, Scott B ^b   Singer, Alexander ^a   Lix, Lisa M ^a   Hitchon, Carol A ^a   El Gabalawy, Renée ^a   Katz, Alan ^a   Fisk, John D ^c   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Anxiety; Depression; Epidemiology; Multiple sclerosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; COMORBIDITY; DEPRESSION; FEMALE; HUMAN; INCIDENCE; MALE; MANITOBA; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; INCIDENCE; MALE; MANITOBA; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; YOUNG ADULT;

EID: 85035198247     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/s13104-017-2958-1     Document Type: Article

References (18)

1. Marrie R, Reider N, Cohen J, Stuve O, Trojano M, Sorensen PS, Cutter G. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler J. 2015;21(3):305-17.
2. Marrie RA, Elliott L, Marriott J, Cossoy M, Blanchard J, Leung S, Yu N. Effect of comorbidity on mortality in multiple sclerosis. Neurology. 2015;85(3):240-7.
3. Marrie RA, Elliott L, Marriott J, Cossoy M, Tennakoon A, Yu N. Comorbidity increases the risk of hospitalizations in multiple sclerosis. Neurology. 2015;84(4):350-8.
4. Marrie RA, Fisk JD, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Evans C, Wolfson C, Svenson LW, et al. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol. 2013;13(1):16.
5. Baxter AJ, Vos T, Scott KM, Norman RE, Flaxman AD, Blore J, Whiteford HA. The regional distribution of anxiety disorders: implications for the Global Burden of Disease Study, 2010. Int J Methods Psychiatr Res. 2014;23(4):422-38.
6. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJL, Vos T, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547.
7. World Health Organization. Mental Health Action Plan 2013-2020. Geneva: World Health Organization; 2013.
8. Keller MB, Boland RJ. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatr. 1998;44(5):348-60.
9. Bockting CL, Hollon SD, Jarrett RB, Kuyken W, Dobson K. A lifetime approach to major depressive disorder: the contributions of psychological interventions in preventing relapse and recurrence. Clin Psychol Rev. 2015;41:16-26.
10. Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy H, et al. Increased incidence of psychiatric disorders in immune-mediated inflammatory disease. J Psychosom Res. 2017;101:17-23.
11. Goldman MD, Cohen JA, Fox RJ, Bethoux FA. Multiple sclerosis: treating symptoms, and other general medical issues. Cleve Clin J Med. 2006;73:177-86.
12. Canadian Community Health Survey - Mental Health (CCHS). http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&Id=119789. Accessed 11 Sep 2017.
13. Chateau D, Metge C, Prior H, Soodeen RA. Learning from the census: the Socio-economic Factor Index (SEFI) and health outcomes in Manitoba. Can J Public Health. 2012;103(8 Suppl 2):S23-7.
14. Patten SB, Svenson LW, Metz LM. Descriptive epidemiology of affective disorders in multiple sclerosis. CNS Spectr. 2005;10(5):365-71.
15. Breslow RE, Klinger BI, Erickson BJ. County drift: a type of geographic mobility of chronic psychiatric patients. Gen Hosp Psychiatry. 1998;20(1):44-7.
16. Marrie RA, Horwitz RI, Cutter G, Tyry T, Campagnolo D, Vollmer T. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and under-treated. Neurology. 2008;70(Suppl 1):A208.
17. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry. 2002;159(11):1862-8.
18. Marrie RA, Walker JR, Graff LA, Lix LM, Bolton JM, Nugent Z, Targownik LE, Bernstein CN. Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease. J Psychosom Res. 2016;89:107-13.